title: Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study.
authors: Catholic University Kang Nam St. Mary Hospital, Seoul, South Korea.
authors: K
authors: K
authors: Park
authors: C
authors: C
authors: Ahn
authors: B K
authors: BK
authors: Bang
authors: C M
authors: CM
authors: Kang
authors: S I
authors: SI
authors: Kim
authors: S J
authors: SJ
authors: Kim
authors: Y S
authors: YS
authors: Kim
authors: Y S
authors: YS
authors: Kim
authors: Y B
authors: YB
authors: Koh
authors: J Y
authors: JY
authors: Kwak
authors: O J
authors: OJ
authors: Kwon
authors: I S
authors: IS
authors: Moon
authors: J I
authors: JI
authors: Moon
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000453:epidemiology; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology* / Q000503:physiopathology / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D015995:Prevalence; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus